Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Engineering Oncogenic Kinases to Activate Apoptotic Machinery: A Novel Rewiring of Bcr-Abl and PKCβII

David Arthur Hoekstra, Louise M Carlson, BS, Kelvin P Lee, MD

Blood (2014) 124 (21): 2222.

https://doi.org/10.1182/blood.V124.21.2222.2222

Published: 2014

Journal Articles

CD28 Regulates Mitochondrial Metabolism in Long Lived Plasma Cells for Survival

Adam T Utley, BS, BA, Cheryl H Rozanski, BS, Louise M Carlson, BS, Kelvin P Lee, MD

Blood (2014) 124 (21): 570.

https://doi.org/10.1182/blood.V124.21.570.570

Published: 2014

Journal Articles

CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma

Megan E. Murray, Catherine M. Gavile, Jayakumar R. Nair, Chandana Koorella, Louise M. Carlson, Daniela Buac, Adam Utley, Marta Chesi, P. Leif Bergsagel, Lawrence H. Boise, Kelvin P. Lee

Blood (2014) 123 (24): 3770–3779.

https://doi.org/10.1182/blood-2013-10-530964

Published: 2014

Includes: Supplemental data

Journal Articles

Progenitor Cell Differentiation Into Dendritic Cells Requires Cytokine Mediated PKC-IRF Relationships

Haley Spangler, Matthew R Farren, Louise M Carlson, BS, Scott Abrams, Kelvin P Lee, MD

Blood (2013) 122 (21): 2449.

https://doi.org/10.1182/blood.V122.21.2449.2449

Published: 2013

Journal Articles

CD28 Regulates Metabolism In Multiple Myeloma For Cell Survival and Proliferation

Adam T Utley, BS, BA, Megan Murray, Ph.D, Louise M Carlson, BS, Matthew R. Farren, B.S., Jayakumar R Nair, Ph.D., Kelvin P Lee, MD

Blood (2013) 122 (21): 5400.

https://doi.org/10.1182/blood.V122.21.5400.5400

Published: 2013

Journal Articles

Reversing Drug Resistance and CD28 Mediated Survival In Myeloma Via The Novel Redox Regulator Thioredoxin

Jayakumar R Nair, Ph.D., Louise M Carlson, BS, Kelvin P Lee, MD

Blood (2013) 122 (21): 756.

https://doi.org/10.1182/blood.V122.21.756.756

Published: 2013

Journal Articles

Targeting the Cellular and Molecular Components of CD28 Mediated Survival Signaling in Multiple Myeloma

Jayakumar R Nair, Ph.D., Megan Murray, Chandana Koorella, Louise M Carlson, Lawrence H. Boise, PhD, Kelvin P Lee, MD

Blood (2012) 120 (21): 722.

https://doi.org/10.1182/blood.V120.21.722.722

Published: 2012

Journal Articles

Prosurvival and Immunosuppressive Functions of CD28 in the Myeloma Tumor Microenvironment

Jayakumar R Nair, Ph.D., Megan Murray, Chandana Koorella, Cheryl H Rozanski, BS, Louise M Carlson, Lawrence H. Boise, PhD, Kelvin P Lee, MD

Blood (2011) 118 (21): 473.

https://doi.org/10.1182/blood.V118.21.473.473

Published: 2011

Journal Articles

Downstream Targets of PKCβII in Dendritic Cell Differentiation,

Haley Spangler, Matthew R Farren, Louise M Carlson, Kelvin P Lee, MD

Blood (2011) 118 (21): 3245.

https://doi.org/10.1182/blood.V118.21.3245.3245

Published: 2011

Journal Articles

Crosstalk Between Notch and CD80/86 Signaling In Multiple Myeloma

Chandana Koorella, Jayakumar R Nair, Ph.D., Louise M Carlson, Kelvin P. Lee, MD

Blood (2011) 118 (21): 1111.

https://doi.org/10.1182/blood.V118.21.1111.1111

Published: 2011

Journal Articles

STAT3 Activity Negatively Regulates PKCβ Promoter Activity, Impairing Dendritic Cell Differentiation

Matthew R Farren, Haley Spangler, Louise M Carlson, Kelvin P Lee, MD

Blood (2011) 118 (21): 185.

https://doi.org/10.1182/blood.V118.21.185.185

Published: 2011

Journal Articles

Rewiring of the Protein Kinase C Beta 2 (PKC βII) and Bcr/Abl Signal Transduction Pathways

David Arthur Hoekstra, II, Louise M Carlson, Kelvin P Lee, MD

Blood (2011) 118 (21): 1673.

https://doi.org/10.1182/blood.V118.21.1673.1673

Published: 2011

Journal Articles

Sustained Antibody Responses Depend on CD28 Function in Bone Marrow Resident Plasma Cells

Cheryl H Rozanski, BS, Lindzy F Dodson, PhD, Ramon Arens, PhD, Louise M Carlson, Lisa M Russell, PhD, Jayakumar R Nair, Ph.D., Asher Chanan-Khan, Lee Ann Garrett-Sinha, PhD, Jonathan M Green, MD, Stephen P Schoenberger, PhD, Lawrence H. Boise, PhD, Kelvin P Lee, MD

Blood (2011) 118 (21): 182.

https://doi.org/10.1182/blood.V118.21.182.182

Published: 2011

Journal Articles

Therapeutically Rewiring Kinase Pathways in BCR-ABL + Leukemias

Louise M Carlson, BA, Sanjay Bansal, PhD, Kelvin P. Lee, MD

Blood (2008) 112 (11): 3197.

https://doi.org/10.1182/blood.V112.11.3197.3197

Published: 2008

Journal Articles

Survival Signals, Growth Cytokines, Immunosuppressive Factors and Their Cellular Perpetrators in the Myeloma Tumor Microenvironment.

Jayakumar R Nair, PhD, Louise M Carlson, PhD, Noreen Ersing, MS, Asher Alban Chanan-Khan, MD, Kelvin P. Lee, MD

Blood (2008) 112 (11): 1664.

https://doi.org/10.1182/blood.V112.11.1664.1664

Published: 2008

Journal Articles

Tumor-Mediated Suppression of Myeloid to Dendritic Cell Differentiation Via Down Regulation of Protein Kinase C βII Expression

Matthew R. Farren, B.S., Louise M Carlson, PhD, Kelvin P. Lee, MD

Blood (2008) 112 (11): 678.

https://doi.org/10.1182/blood.V112.11.678.678

Published: 2008

Journal Articles

CD28-mediated regulation of multiple myeloma cell proliferation and survival

Nizar J. Bahlis, Anne M. King, Despina Kolonias, Louise M. Carlson, Hong Yu Liu, Mohamad A. Hussein, Howard R. Terebelo, Gerald E. Byrne, Jr, Bruce L. Levine, Lawrence H. Boise, Kelvin P. Lee

Blood (2007) 109 (11): 5002–5010.

https://doi.org/10.1182/blood-2006-03-012542

Published: 2007

Journal Articles

Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells

Esther A. Obeng, Louise M. Carlson, Delia M. Gutman, William J. Harrington, Jr, Kelvin P. Lee, Lawrence H. Boise

Blood (2006) 107 (12): 4907–4916.

https://doi.org/10.1182/blood-2005-08-3531

Published: 2006

Journal Articles

CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival.

Kelvin P. Lee, MD, Nizar J. Bahlis, MD, Anne M. King, MS, Despina Kolonias, BS, Louise M. Carlson, BS, Mohamad Hussein, MD, Howard Terebolo, DO, Gerald E. Byrne, Jr., MD, Bruce L. Levine, Ph.D, Lawrence H. Boise, Ph.D

Blood (2005) 106 (11): 355.

https://doi.org/10.1182/blood.V106.11.355.355

Published: 2005

NARROW

Engineering Oncogenic Kinases to Activate Apoptotic Machinery: A Novel Rewiring of Bcr-Abl and PKCβII

CD28 Regulates Mitochondrial Metabolism in Long Lived Plasma Cells for Survival

CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma

Progenitor Cell Differentiation Into Dendritic Cells Requires Cytokine Mediated PKC-IRF Relationships

CD28 Regulates Metabolism In Multiple Myeloma For Cell Survival and Proliferation

Reversing Drug Resistance and CD28 Mediated Survival In Myeloma Via The Novel Redox Regulator Thioredoxin

Targeting the Cellular and Molecular Components of CD28 Mediated Survival Signaling in Multiple Myeloma

Prosurvival and Immunosuppressive Functions of CD28 in the Myeloma Tumor Microenvironment

Downstream Targets of PKCβII in Dendritic Cell Differentiation,

Crosstalk Between Notch and CD80/86 Signaling In Multiple Myeloma

STAT3 Activity Negatively Regulates PKCβ Promoter Activity, Impairing Dendritic Cell Differentiation

Rewiring of the Protein Kinase C Beta 2 (PKC βII) and Bcr/Abl Signal Transduction Pathways

Sustained Antibody Responses Depend on CD28 Function in Bone Marrow Resident Plasma Cells

Therapeutically Rewiring Kinase Pathways in BCR-ABL + Leukemias

Survival Signals, Growth Cytokines, Immunosuppressive Factors and Their Cellular Perpetrators in the Myeloma Tumor Microenvironment.

Tumor-Mediated Suppression of Myeloid to Dendritic Cell Differentiation Via Down Regulation of Protein Kinase C βII Expression

CD28-mediated regulation of multiple myeloma cell proliferation and survival

Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells

CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only